KARLEY TRAUTMAN: Open Payments
NPI 1376867945 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 12 payments from 10 companies in 2025. Trend: 2023 $112 · 2024 $416 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $90 |
| Janssen Biotech, Inc. | 2 | $62 |
| Geron Corporation | 1 | $36 |
| Eisai Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $28 |
| ABBVIE INC. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $27 |
| PFIZER INC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
Products named: KISQALI, RYTELO, TECVAYLI, Lenvima, WAYRILZ, EPKINLY, Enhertu, RYBREVANT.
Industry payments across CO — which companies pay providers there.
